Variable | SLE patients | |
---|---|---|
Frequency (No. = 40) | Percentage (%) | |
Sex | ||
Female | 34 | 85.0 |
Male | 6 | 15.0 |
Age in years, Mean ± SD | 30.9 ± 8.2 | |
Disease Duration (years), Mean ± SD | 5.5 ± 4.2 | |
BMI, Mean ± SD | 26.95 ± 4.534 | |
Joint involvement | ||
Number of tender joints, Mean ± SD | 5.1 ± 4.7 | |
Number of swollen joints, Mean ± SD | 1.9 ± 2 | |
Clinical arthritis | 24 | 60.0 |
Deformity (Jaccoud arthropathy) | 6 | 15.0 |
Arthritis | ||
Asymptomatic | 14 | 35.0 |
Symptomatic | 26 | 65.0 |
Cutaneous manifestations | 30 | 75.0 |
Raynaud’s | 2 | 5.0 |
Neurological manifestations | 8 | 20.0 |
Cardiac manifestations | 18 | 45.0 |
Pulmonary manifestations | 10 | 25.0 |
Nephritis | 32 | 80.0 |
Classes of renal biopsy | ||
Indicated but the patient refused | 6 (15%) | 15.0 |
Not indicated | 18 (45%) | 45.0 |
Class III LN | 4 (10%) | 10 |
Class IV LN | 6 (15%) | 15 |
Class V LN | 6 | 15 |
ECLAM score, Mean ± SD | 5.2 ± 2.5 | |
HAQ score, Mean ± SD | 0.51 ± 0.3 | |
Medications | ||
Pulse IV steroids | 22 | 55.0 |
IV Cyclophosphamide (CYC) | 18 | 45.0 |
Prednisolone (oral steroids) | 40 | 100.0 |
MMF | 6 | 15.0 |
AZA | 10 | 25.0 |
HCQ | 38 | 95.0 |